Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990643914> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W1990643914 endingPage "202" @default.
- W1990643914 startingPage "196" @default.
- W1990643914 abstract "Improvements in quality of life (QoL) and disease-related symptoms are key goals in the treatment of hormone refractory prostate cancer (HRPC). Our aim was to evaluate the impact of gefitinib on QoL of patients with HRPC.Patients with HRPC received gefitinib 250 mg daily in addition to antiandrogen plus luteinizing hormone-releasing hormone (LHRH) analogue for at least 2 months or until disease progression. QoL was evaluated monthly by the European Organisation for Research on the Treatment of Cancer (EORTC) QLQ-C30 questionnaire. Pain was assessed daily by patients and scored by visual analogue scale and analgesic consumption in a diary. Monthly pain intensity was estimated using the McGill-Melzack questionnaire.Analysis of global health status according to EORTC QLQ-C30 showed an improvement of the status in only 6 patients (26%). The greatest benefit in the patients was in the subscale representing prostate-specific concerns (including appetite, pain, physical comfort, and genitourinary function). Improvement of symptoms was correlated with antiandrogen withdrawal. Global health status and QoL decreased during treatment according to tumor progression.Among HRPC patients treated with gefitinib, improvement of symptoms preceded evidence of biochemical response of prostate-specific antigen following antiandrogen withdrawal. These findings suggest no beneficial effect of gefitinib in QoL improvement." @default.
- W1990643914 created "2016-06-24" @default.
- W1990643914 creator A5001805404 @default.
- W1990643914 creator A5003897511 @default.
- W1990643914 creator A5052353123 @default.
- W1990643914 creator A5064646828 @default.
- W1990643914 creator A5083671873 @default.
- W1990643914 creator A5088045830 @default.
- W1990643914 date "2009-01-01" @default.
- W1990643914 modified "2023-09-27" @default.
- W1990643914 title "Health-related quality of life in patients with hormone refractory prostate cancer receiving gefitinib." @default.
- W1990643914 cites W1963592300 @default.
- W1990643914 cites W1998284759 @default.
- W1990643914 cites W2004909463 @default.
- W1990643914 cites W2005885733 @default.
- W1990643914 cites W2022288928 @default.
- W1990643914 cites W2031065729 @default.
- W1990643914 cites W2065526121 @default.
- W1990643914 cites W2066086539 @default.
- W1990643914 cites W2105258029 @default.
- W1990643914 cites W2139248078 @default.
- W1990643914 cites W2160064859 @default.
- W1990643914 cites W2165611177 @default.
- W1990643914 cites W2165631552 @default.
- W1990643914 cites W2167571044 @default.
- W1990643914 cites W2168431047 @default.
- W1990643914 cites W2170071316 @default.
- W1990643914 cites W2400225833 @default.
- W1990643914 cites W62578250 @default.
- W1990643914 doi "https://doi.org/10.1159/000200800" @default.
- W1990643914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19322010" @default.
- W1990643914 hasPublicationYear "2009" @default.
- W1990643914 type Work @default.
- W1990643914 sameAs 1990643914 @default.
- W1990643914 citedByCount "4" @default.
- W1990643914 countsByYear W19906439142013 @default.
- W1990643914 countsByYear W19906439142015 @default.
- W1990643914 countsByYear W19906439142021 @default.
- W1990643914 crossrefType "journal-article" @default.
- W1990643914 hasAuthorship W1990643914A5001805404 @default.
- W1990643914 hasAuthorship W1990643914A5003897511 @default.
- W1990643914 hasAuthorship W1990643914A5052353123 @default.
- W1990643914 hasAuthorship W1990643914A5064646828 @default.
- W1990643914 hasAuthorship W1990643914A5083671873 @default.
- W1990643914 hasAuthorship W1990643914A5088045830 @default.
- W1990643914 hasConcept C121608353 @default.
- W1990643914 hasConcept C126322002 @default.
- W1990643914 hasConcept C143998085 @default.
- W1990643914 hasConcept C159110408 @default.
- W1990643914 hasConcept C2779322244 @default.
- W1990643914 hasConcept C2779438470 @default.
- W1990643914 hasConcept C2779951463 @default.
- W1990643914 hasConcept C2780192828 @default.
- W1990643914 hasConcept C2780580887 @default.
- W1990643914 hasConcept C2781406297 @default.
- W1990643914 hasConcept C71924100 @default.
- W1990643914 hasConceptScore W1990643914C121608353 @default.
- W1990643914 hasConceptScore W1990643914C126322002 @default.
- W1990643914 hasConceptScore W1990643914C143998085 @default.
- W1990643914 hasConceptScore W1990643914C159110408 @default.
- W1990643914 hasConceptScore W1990643914C2779322244 @default.
- W1990643914 hasConceptScore W1990643914C2779438470 @default.
- W1990643914 hasConceptScore W1990643914C2779951463 @default.
- W1990643914 hasConceptScore W1990643914C2780192828 @default.
- W1990643914 hasConceptScore W1990643914C2780580887 @default.
- W1990643914 hasConceptScore W1990643914C2781406297 @default.
- W1990643914 hasConceptScore W1990643914C71924100 @default.
- W1990643914 hasIssue "2" @default.
- W1990643914 hasLocation W19906439141 @default.
- W1990643914 hasLocation W19906439142 @default.
- W1990643914 hasOpenAccess W1990643914 @default.
- W1990643914 hasPrimaryLocation W19906439141 @default.
- W1990643914 hasRelatedWork W1980998207 @default.
- W1990643914 hasRelatedWork W1981215886 @default.
- W1990643914 hasRelatedWork W2034126867 @default.
- W1990643914 hasRelatedWork W2079700809 @default.
- W1990643914 hasRelatedWork W2080649762 @default.
- W1990643914 hasRelatedWork W2087041286 @default.
- W1990643914 hasRelatedWork W2325745741 @default.
- W1990643914 hasRelatedWork W2801577274 @default.
- W1990643914 hasRelatedWork W4362475233 @default.
- W1990643914 hasRelatedWork W2530851007 @default.
- W1990643914 hasVolume "82" @default.
- W1990643914 isParatext "false" @default.
- W1990643914 isRetracted "false" @default.
- W1990643914 magId "1990643914" @default.
- W1990643914 workType "article" @default.